| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| INTLI - Finanziamenti internazionali |
The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis (2° annualità)
|
|
Ongoing | 2023 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes (HappyMums)
|
|
Ongoing | 2022 |
| Horizon Europe - Marie Skłodowska-Curie actions - Staff Exchanges |
Comprehensive and personalized assessment of acute coronary syndrome by multiomic approach and artificial intelligence strategy (CardioSCOPE)
|
|
Ongoing | 2023 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
FuEl ThE bRaiN In healtThY aging and agE-relateD diseases (ETERNITY)
|
|
Ongoing | 2023 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Breaking the barrier -An integrated multidisciplinary approach to killGram-negative bacteria through existing antibiotics by making their outer membrane permeable (BREAKthrough)
|
|
Ongoing | 2023 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Metal-containing Radical Enzymes (MetRaZymes)
|
|
Ongoing | 2022 |
| Horizon Europe - European Partnership |
Partnership for the Assessment of Risks from Chemicals (PARC)
|
|
Ongoing | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
The impact of early life stress in later life (EarlyCause)
|
|
Ongoing | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia (RECOGNISED)
|
|
Ongoing | 2020 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Twinning towards excellence in alternative methods for toxicity assessment (TWINALT)
|
|
Ongoing | 2020 |
| FON_NAZ - Bandi Altre Fondazioni |
Pharmacological block of the prokineticin system and of microglia activation to treat pain and mood disorders in Fabry-Anderson disease
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Connecting craniofacial malformations with neural crest splicing defects by defining the role of nuclear cyclophilin NKTR (GMR22T1054)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Linking inflammation to progression of neurodegeneration in Parkinson’s disease (LINKING PARK)
|
|
Ongoing | 2023 |
| DECC - Bando Dipartimenti di Eccellenza |
Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di SCIENZE FARMACOLOGICHE E BIOMOLECOLARI
|
|
Ongoing | 2023 |
| CONTR_OINT - Contratti di ricerca finanziata da Organizzazioni Internazionali |
The Role of Immune Pathways in The Risk and Development of Depression in Adolescence: research protocol of the IDEA-FLAME study
|
|
Ongoing | 2022 |
| CONTR_ASPR - Contratti di ricerca finanziata da associazioni e altri soggetti privati |
Valutazione dell’impatto della somministrazione di una statina (atorvastatina) e dell’acido bempedoico sull’attività mitocondriale del muscolo scheletrico
|
|
Ongoing | 2023 |
| CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Molecular mechanisms of NLRP3-inflammasome inhibition by Leishmania infantum-derived factors in the neuropathogenesis of Alzheimer's disease
|
|
Ongoing | 2023 |
